Concepedia

Campbell McInnes

CM

Statistics

Publications

41

Citations

1.6K

H-Index

23

Active since

1993

Affiliations

University of South Carolina(Current)

Cyclacel Pharmaceuticals (United Kingdom)

University of Thessaly

University of Alberta

University of Nottingham

Campbell McInnes is an author at University of South Carolina specializing in medicinal chemistry, drug discovery, and ligand binding.

ORCID

Publications per year

1993–2024

41

Publications

41

Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases

Zuping Xia, Christian Knaak, Jian Ma et al. · Journal of Medicinal Chemistry · 2008 · 193 citations · Full text

, , +17

Discovery of<i>N</i>-Phenyl-4-(thiazol-5-yl)pyrimidin-2-amine Aurora Kinase Inhibitors

Shudong Wang, Carol Midgley, Frédéric Scaërou et al. · Journal of Medicinal Chemistry · 2010 · 101 citations · Full text

, , +17

Discovery and Characterization of 2-Anilino-4- (Thiazol-5-yl)Pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents

Shudong Wang, Gary Griffiths, Carol Midgley et al. · Chemistry & Biology · 2010 · 101 citations · Full text

, , +14

Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance

Campbell McInnes, A. Mazumdar, Mokdad Mezna et al. · Nature Chemical Biology · 2006 · 100 citations · Full text

, , +12

Quantification of the Effects of Ionic Strength, Viscosity, and Hydrophobicity on Protein–Ligand Binding Affinity

Christos Papaneophytou, Asterios I. Grigoroudis, Campbell McInnes et al. · ACS Medicinal Chemistry Letters · 2014 · 69 citations · Full text

, , +17

1–5 of 41